Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform - Johnson & Johnson

By Unknown | Published: Jun 08, 2026

NEW BRUNSWICK, NJ (June 8, 2026) Johnson & Johnson (NYSE: JNJ) today announced it has entered into a definitive agreement to acquire Firefly Bio, Inc., a biotechnology company advancing its propr… [+5388 chars]